News, events and chat from Sheffield and South Yorkshire.
Endometriosis groups ‘crying out’ for cut in diagnosis time
Women with endometriosis in the UK often experience prolonged delays before receiving a diagnosis, sometimes waiting years. The National Institute for Health and Care Excellence has announced new guidance to introduce two non-invasive tests through the NHS, trialed over three years in England and Wales, to accelerate diagnosis. These tests—a saliva examination and an abdominal sensor measurement—aim to help GPs identify the condition and refer patients to specialists more quickly.
Despite welcoming the initiative, patient advocacy groups highlight significant implementation concerns. Many worry that GPs lack sufficient understanding of endometriosis to identify suitable candidates for testing, and that infrastructure gaps—particularly the shortage of endometriosis specialists and uneven service provision across regions—could leave patients waiting lengthy periods even after diagnosis. While some areas have dedicated centres, others lack specialist support entirely, meaning the new tests alone may not fully address the systemic delays patients currently face.
In short
- NICE introduces two non-invasive tests to accelerate endometriosis diagnosis in England and Wales over a three-year trial
- Patient advocacy groups welcome the tests but warn that GP knowledge gaps and specialist shortages remain critical barriers to timely care
- Service provision is geographically uneven, raising concerns that diagnosis acceleration won't solve delays in accessing specialist treatment
Steelman: both sides, in good faith
The strongest fair case each way — we don't pick a winner.
The case for
The diagnostic tests represent practical progress that will help GPs identify endometriosis more efficiently and accelerate referrals to specialists, addressing a key bottleneck in patient care. Although specialist capacity remains a separate concern, trialling the tests over three years allows implementation to be refined, and achieving faster diagnosis is a worthwhile step forward even as parallel efforts address infrastructure gaps.
The case against
Introducing diagnostic tests without simultaneous investment in specialist services risks worsening outcomes by creating a larger cohort of diagnosed patients facing existing treatment delays. Unless specialist capacity is expanded across all regions alongside test implementation, these measures may simply shift the bottleneck from diagnosis to treatment, disappointing patients and leaving the systemic problem unresolved.
Explained simply
Endometriosis is a condition where tissue similar to womb lining grows in other parts of the body, causing pain and sometimes fertility problems. Women with the condition in the UK often wait years for a diagnosis, which delays treatment and affects their quality of life. This matters because earlier diagnosis could help patients receive appropriate care sooner.
The National Institute for Health and Care Excellence has introduced new guidance to speed up diagnosis through two simple tests available on the NHS. These are a saliva test and an abdominal sensor measurement that can help doctors identify the condition without invasive procedures. The tests will be trialled over three years in England and Wales, potentially allowing GPs to spot endometriosis more quickly and refer patients to specialists faster.
However, patient groups warn the new tests alone may not solve the problem. Many GPs lack knowledge about endometriosis and may not know when to use the tests, and there is a shortage of specialist centres across the country. This means some patients could still face long waits even after a diagnosis is made, particularly in areas without dedicated endometriosis services.